The present invention is related to N-hydroxyamide derivatives of Formula (I)and use thereof in particular for the treatment and/or prophylaxis of autoimmunedisorders, inflammatory diseases, cardiovascular diseases, neurodegenerativediseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis,arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonaryfibrosis.